Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-Blind, Placebo-Controlled Study of Nesiritide in Acute Decompensated Heart Failure
2007-001670-84Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) comparing Nesiritide + standard care with Placebo + standard care (2 arms). Primary endpoints: Composite of heart failure rehospitalization and all-cause mortality through Day 30, Dyspnea improvement by Likert scale at 6 hours and 1 more. Started Jul 2007; status: completed.
02
Drugs
nesiritide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2007-001670-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001670-84.